- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03916692
GRAPE • Glycemic Response of Amylopectin Containing Drinks (GRAPE)
Glycemic Response of Amylopectin Containing Drinks
To quantify the glycemic index of the SP energy-smart-based nutrition supplement and the SP Glucose-support formula as compared to a glucose drink. We hypothesized that both the energy-smart-based nutritional supplement and the SP Glucose-support formula will have low glycemic index.
The aim of the study is to quantify the glycemic index of the SP energy-smart-based nutrition supplement and the SP Glucose-support formula as compared to a glucose drink. We hypothesized that both the energy-smart-based nutritional supplement and the SP Glucose-support formula will have low glycemic index.
Study Overview
Status
Conditions
Detailed Description
Subjects: 9 non-diabetic (HbA1c < 6.5) males aged 30-55 years with body mass indices ranging from 27.5 to 35 kg∙m-2. Individuals with impaired glucose tolerance will be included as long as they are not diagnosed with diabetes and their HbA1c is less than 6.5.
Preliminary Testing: Medical history, weight, height, body composition via dual x-ray absorptiometry (DXA) and glycosylated hemoglobin (HbA1c) measurement.
Protocol: After a 10-hour overnight fast, subjects will complete 3 experimental visits in which they will ingest one of three beverages in a randomized order. During experimental visits subjects will either be given the following 3 experimental drinks:
- Full SP-glucose balance formula (200 kcal)
- Energy smart carbohydrate blend (50 g, 200 kcal)
- Liquid dextrose solution in the form of TRUTOL ® Glucose Tolerance Test Beverage (50 g, 200 kcal)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85004
- Arizona Biomedical Collaborative
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI 27.5 to 35 kg∙m-2
Exclusion Criteria:
- Diagnosed diabetes
- HbA1c > 6.5
- competitive athletes
- body weigh change > 3kg during last month
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Standard Process - glucose balance
Standard Process - glucose balance formula (200 kcal)
|
Meal replacement drink containing 200 kcal
Other Names:
|
Experimental: Energy smart Carbohydrate blend
Energy smart carbohydrate blend (50 grams, 200 kcal)
|
Carbohydrate blend drink designed for low glycemic responses containing 200 kcal
|
Active Comparator: Liquid Dextrose Control
Liquid dextrose solution in the form of TRUTOL ® Glucose Tolerance Test Beverage (50 grams, 200 kcal)
|
Liquid Dextrose drink of 200 kcal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Area Under the Curve of Glucose
Time Frame: 120 minutes
|
Positive integer of the area under the Curve of glucose
|
120 minutes
|
Area Under the Curve for Insulin
Time Frame: 120 minutes
|
Positive integer of the area under the Curve of insulin
|
120 minutes
|
Blood glucose
Time Frame: 30, 60 and 120 minutes of the glucose challenge
|
Blood glucose levels
|
30, 60 and 120 minutes of the glucose challenge
|
Blood insulin
Time Frame: 30, 60 and 120 minutes of the glucose challenge
|
Blood insulin levels
|
30, 60 and 120 minutes of the glucose challenge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
c-peptide
Time Frame: 30, 60, and 120 minutes of the glucose challenge
|
Blood levels of c-peptide
|
30, 60, and 120 minutes of the glucose challenge
|
glucagon
Time Frame: 30, 60, and 120 minutes of of the glucose challenge
|
Blood levels of glucagon
|
30, 60, and 120 minutes of of the glucose challenge
|
Leptin
Time Frame: 30, 60, and 120 minutes of the glucose challenge
|
Blood levels of leptin
|
30, 60, and 120 minutes of the glucose challenge
|
Adiponectin
Time Frame: 30, 60, and 120 minutes of the glucose challenge
|
Blood levels of adiponectin
|
30, 60, and 120 minutes of the glucose challenge
|
glucagon-like-peptide-1
Time Frame: 30, 60, and 120 minutes of the glucose challenge
|
Blood levels of glucagon-like-peptide-1
|
30, 60, and 120 minutes of the glucose challenge
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Stavros Kavouras, PhD, Arizona State University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FP00016578
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glycemic Index
-
Mondelēz International, Inc.Reading Scientific Services Ltd.Completed
-
Aga Khan UniversityUnknown
-
PepsiCo Global R&DCompletedGlycemic IndexUnited States
-
Danone Asia Pacific Holdings Pte, Ltd.Completed
-
Azienda Ospedaliera Specializzata in Gastroenterologia...Unknown
-
Nutrition Institute, SloveniaSlovenian Research Agency; Valens Int. d.o.o., Slovenija; Community Health Centre...CompletedGlycemic IndexSlovenia
-
Azienda di Servizi alla Persona di PaviaRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompleted
-
Nutrition Institute, SloveniaValens Int. d.o.o., SlovenijaCompleted
Clinical Trials on Carbohydrate drink
-
Jessica GrayUnknownPostoperative Complications | Postoperative Pain | Sleep | Satisfaction | Postoperative NauseaCanada
-
Coombe Women and Infants University HospitalRecruitingFasting | Glucose, Low Blood | Cesarean Delivery Affecting FetusIreland
-
University of ArizonaNova BiomedicalRecruitingCesarean Section | Enhanced Recovery After SurgeryUnited States
-
University of Western Ontario, CanadaUnknown
-
Medical University of GdanskRecruitingBariatric Surgery | Carbohydrate LoadingPoland
-
King's College LondonCompletedGlucose Metabolism Disorders | Appetitive BehaviorUnited Kingdom
-
University of OxfordUnknown
-
Hospital for Special Surgery, New YorkRecruitingLength of Stay | Same-day DischargeUnited States
-
University of OuluSeinajoki Central HospitalCompleted
-
McGill University Health Centre/Research Institute...Mitacs; Medtronic - MITGCompletedLaparoscopic Abdominal SurgeryCanada